PMC6884023_01
MRI of the head and hematoma volume changes during atorvastatin Treatment. The head MRI scans were performed 2 days before the initiation of atorvastatin therapy (A) and 3 months after therapy was started (B). Images are from T2-weighted sequencing. (C) shows a gradual decrease in hematoma volume after atorvastatin treatment (

Supplementary Figures 1-6

).
fphar-10-01343-g001.jpg
PMC6884023_01_fphar-10-01343-g001.jpg
f1
An MRI scan revealed a left temple lobe arachnoid cyst and a left frontal and temporal-parietal subdural hematoma ( Supplementary Figure 1A  and  B ). The patient was treated with cyst cerebral cistern ostomy, and the subdural hematoma was removed under neuroendoscope in our hospital ( Supplementary Figure 1C  and  D ). A CT scan of the head showed a left subdural hematoma in the frontal and temporal-parietal regions ( Supplementary Figure 1E  and  F ). The postoperative symptoms of the patient's caused by cranial hypertension related to the subdural hematoma resolved and the patient recovered well ( Supplementary Figure 1G  and  H ). An MRI examination identified postoperative changes to the left temple lobe arachnoid cyst, and formation of a left frontal- temporal subdural hematoma ( Figure 1A ). Follow-up monitoring was done monthly for 12 months after the initial atorvastatin treatment ( Figure 1C ). B ). By the third month after the initial treatment, neurological function had fully recovered and the hematoma had completely resolved ( Figure 1B ).